Vandana Midha

Vandana Midha

Department of Gastroenterology, DMC, Ludhiana, India | Department of Internal Medicine, Dayanand Medical College, 141 001, Ludhiana, India | Department of Medicine, Dayanand ...

KOL Resume for Vandana Midha  (ulcerative, ulcerative colitis, colitis, colitis ulcerative)

Year
2022

Department of Gastroenterology, DMC, Ludhiana, India

2021

Department of Internal Medicine, Dayanand Medical College, Ludhiana, India.

2020

Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India.

2019

Department of Internal Medicine, Dayanand Medical College, Ludhiana, Punjab, India

2018

Dayanand Medical College, Ludhiana, Punjab, India

2017

Department of Internal Medicine Dayanand Medical College Ludhiana Punjab India

2016

Dayanand Medical College and Hospital, 141004, Ludhiana, India

2014

Dayanand Medical College and Hospital, Punjab, India

2013

Department of Medicine, Dayanand Medical College and Hospital, Tagore Nagar, 141 001, Ludhiana, India

2012

Department of Medicine, Dayanand Medical College, Tagore Nagar, Civil Lines, 141 001, Ludhiana, India

2011

Dayanand Medical College and Hospital, Ludhiana, Punjab, India

2010

Departments of Gastroenterology, Medicine and Pathology, Dayanand Medical College and Hospital, 141 001, Ludhiana, India

2009

Department of Gastroenterology and Medicine, Dayanand Medical College and Hospital, Ludhiana, India

2007

Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

2006

Department of Gastroenterology, Dayanand Medical College & Hospital, Ludhiana, India

2003

Department of Community Medicine, Christian Medical College and Hospital, Ludhiana, Punjab, India

2002

From the Departments of Medicine (V.M., G.A.), Pathology (N.S.), and Gastroenterology (A.S.), Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Department of Medicine Dayanand Medical College and Hospital, Ludhiana, India

2001

Department of Medicine, Dayanand Medical College & Hospital, Ludhiana, India

2000

Department of Medicine and Pathology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India

 

Prominent publications by Vandana Midha

KOL Index score: 13550

BACKGROUND: Celiac disease, as of today, is said to exist in almost all parts of the world, although it is rare among people of purely African-Caribbean, Japanese and Chinese background. The disease has also been considered uncommon in India until recently. Hospital records have revealed an increasing trend of the disease in predominantly wheat-eating areas of North India. The aim of the present study was to determine the prevalence of celiac disease among school children in Punjab, ...

Known for Celiac Disease |  North India |  School Children |  Anti Ttg |  Study Prevalence
KOL Index score: 13123

Hepatitis C virus (HCV) genotypes help to tailor the treatment response, but their influence on the disease severity and association with hepatic steatosis is not well understood. The prevalence of HCV genotypes and their correlation with the histopathological severity of liver disease and steatosis in Indian patients were studied. HCV-RNA and genotyping was carried out in 398 patients with chronic hepatitis C. Liver biopsy was available in 292 (73.4%) patients. The severity of liver ...

Known for Liver Disease |  Genotype 3 |  Patients Chronic Hepatitis |  Hepatic Steatosis |  Histological Activity
KOL Index score: 12200

OBJECTIVES: To study the role of faecal microbiota transplantation [FMT] in maintenance of remission in ulcerative colitis [UC].

METHODS: In this pilot study, patients with UC in clinical remission achieved after multi-session FMT were randomly allocated to either maintenance FMT or placebo colonoscopic infusion every 8 weeks, for 48 weeks. The standard of care [SOC] therapy was continued in all patients. The primary endpoint was maintenance of steroid-free clinical remission [Mayo score ...

Known for Patients Fmt |  Ulcerative Colitis |  Microbiota Transplantation |  Clinical Remission |  Mayo Score
KOL Index score: 11706

INTRODUCTION: Ulcerative colitis occurs worldwide. It is considered common in most of Europe and North America and uncommon in most of the developing Asian countries. The incidence/prevalence of ulcerative colitis varies not only according to geographical region but also with race and ethnicity. There are no reported data from India on the incidence of the disease and its prevalence.

MATERIAL AND METHODS: A house to house survey was conducted by questionnaire, formulated to enquire about ...

Known for Ulcerative Colitis |  North India |  Incidence Prevalence |  Suspected Cases |  100 000 Inhabitants
KOL Index score: 11499

BACKGROUND AND AIMS: In chronic hepatitis C virus (HCV) infection with genotype 3, therapy with pegylated interferon (peg-IFN) alfa-2b in a dose of 1.5 mug/kg/week and ribavirin (800-1000 mg/day) is recommended for 24 weeks. Reduced doses of peg-IFN may increase compliance and decrease cost and adverse events. This study aimed to assess the safety and efficacy of two different regimens of peg-IFN alfa-2b, in combination with ribavirin, in genotype 3 patients.

METHODS: A total of 103 ...

Known for Pegylated Interferon |  Genotype 3 |  Patients Groups |  24 Weeks |  Peg Ifn
KOL Index score: 10513

BACKGROUND: Three common disease susceptibility variants in the NOD2 gene are associated with inflammatory bowel disease in Caucasians, but not in Asians. Aim To screen for NOD2 variants and examine susceptibility for inflammatory bowel disease in North Indians.

METHODS: A case-control study was carried out in Punjab, India. Confirmed cases of ulcerative colitis and Crohn's disease and healthy controls matched for age (+/-10 years) and ethnicity were studied. Besides genotyping the three ...

Known for Ulcerative Colitis |  North Indians |  Nod2 Variants |  Inflammatory Bowel Disease |  Allelic Heterogeneity
KOL Index score: 10257

The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in 2009. With international groups volunteering to join, the "APASL ACLF Research Consortium (AARC)" was formed in 2012, which continued to collect prospective ACLF patient data. Based on the prospective data analysis of nearly 1400 patients, the AARC consensus was published in 2014. In the past nearly ...

Known for Liver Failure |  Autoimmune Hepatitis |  Asian Pacific Association |  Acute Chronic |  Apasl Aclf
KOL Index score: 9603

AIM: To evaluate the role of azathioprine (AZA) in Indian patients with ulcerative colitis over longer duration of time.

METHODS: One hundred fifty six patients with ulcerative colitis who were treated with AZA from January 1995 to December 2003 were reviewed. The indications for its use were as follows: (1) steroid dependent and steroid refractory disease; (2) Azathioprine monotherapy for naive patients with severe disease; and (3) combination therapy (AZA + sulfasalazine or ...

Known for Ulcerative Colitis |  Azathioprine Aza |  Drug Therapy |  Gastrointestinal Agents |  Humans Immunosuppressive
KOL Index score: 9352

BACKGROUND AND AIM: The introduction of sofosbuvir has revolutionized the treatment of chronic hepatitis C. This study was planned to observe whether the efficacy and tolerability of sofosbuvir-based regimens demonstrated in phase 3 clinical trial results translate into real-life clinical practice.

METHODS: This prospective, non-randomized observational study conducted in Dayanand Medical College and Hospital, Punjab, included all consecutive treatment-naïve patients with chronic ...

Known for Chronic Hepatitis |  Sofosbuvir Ribavirin |  12 Weeks |  Svr Rates |  Drug Therapy
KOL Index score: 8683

Background. The search is on to find more effective drug regimens for patients with severe ulcerative colitis, as conventional drugs such as sulfasalazine and its congeners fail to prevent relapse in a significant number of patients. Azathioprine has also been reported to be useful as a steroid-sparing drug in patients who suffer from frequent relapses. As these drugs when used individually fail to sustain remission in a significant number of patients, we evaluated the combination of ...

Known for Patients Azathioprine |  Ulcerative Colitis |  Combination Therapy |  Maintenance Remission |  Sulfasalazine Placebo
KOL Index score: 8449

Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of European origin. In this study, we attempted to replicate these findings in an ethnically distinct north Indian UC cohort. 648 UC cases and 850 controls were genotyped using Infinium Human ...

Known for Ulcerative Colitis |  North Indians |  Susceptibility Loci |  Genome Wide |  Limited Replication
KOL Index score: 8402

OBJECTIVES: Acute insults from viruses, infections, or alcohol are established causes of decompensation leading to acute-on-chronic liver failure (ACLF). Information regarding drugs as triggers of ACLF is lacking. We examined data regarding drugs producing ACLF and analyzed clinical features, laboratory characteristics, outcome, and predictors of mortality in patients with drug-induced ACLF.

METHODS: We identified drugs as precipitants of ACLF among prospective cohort of patients with ...

Known for Liver Failure |  Patients Aclf |  Induced Acute |  Predictors Mortality |  Antituberculosis Drugs
KOL Index score: 8379

BACKGROUND & AIMS: Probiotics can maintain ulcerative colitis (UC) in remission effectively, but little is known of their ability to induce remission. We conducted a multicenter, randomized, double-blind, placebo-controlled trial of a high-potency probiotic, VSL#3, for the treatment of mild-to-moderately active UC.

METHODS: Adult patients with mild-to-moderate UC were assigned randomly to groups that were given 3.6 x 10(12) CFU VSL#3 (n = 77) or placebo (n = 70), twice daily for 12 ...

Known for Ulcerative Colitis |  Remission Patients |  Probiotic Preparation |  Moderately Active |  12 Weeks
KOL Index score: 8378

Genotype imputation of the human leukocyte antigen (HLA) region is a cost-effective means to infer classical HLA alleles from inexpensive and dense SNP array data. In the research setting, imputation helps avoid costs for wet lab-based HLA typing and thus renders association analyses of the HLA in large cohorts feasible. Yet, most HLA imputation reference panels target Caucasian ethnicities and multi-ethnic panels are scarce. We compiled a high-quality multi-ethnic reference panel based ...

Known for Reference Panel |  Hla Class |  African Ancestry |  Large Cohorts |  Association Analyses

 

Vandana Midha: Influence Statistics

Sample of concepts for which Vandana Midha is among the top experts in the world.
Concept World rank
histological remission fmt #2
pegylatedinterferon alfa 2b #2
variable immunogenic #2
india cyclosporine #2
uc genetics #2
placebo colonoscopic infusion #2
comorbid disorders outcome #2
patients chc g1 #2
epitopes varieties #2
0 histological #2
reallife setting india #2
ifnγ histology #2
cohorts study period #2
cevr 36 #2
anemia ayurvedic medicines #2
tcell proliferation rate #2
6 aza #2
innocuous varieties #2
incidental benefits #2
infected individuals punjab #2
αgliadin gene sequences #2
long term uc #2
hospital punjab #2
overwhelming genetics #2
remission fmt protocol #2
india celiac #2
40 3258 years #2
svr rates genotypes #2
purpose aimresults #2
exemptia induction #2
dayanand medical college #2
exemptia week #2
patients lead intoxication #2
iga anti‐tissue #2
± genotype #2
hepatitis genotypes india #2
variety c273 #2
asia inflammatory #2
γ histology #2
ayurvedic penicillamine #2
needles common presentation #2
chc g1 patients #2
prognostic clinical application #2
representative wheat varieties #2

Key People For Ulcerative Colitis

Top KOLs in the world
#1
William J Sandborn∥
ulcerative colitis inflammatory bowel disease certolizumab pegol
#2
JeanFr’ed’eric JeanFrederic
ulcerative colitis inflammatory bowel disease ibd patients
#3
Stephen B Hanauer
ulcerative colitis inflammatory bowel disease certolizumab pegol
#4
Rutgeerts RUTGEERTS
ulcerative colitis crohns disease mucosal healing
#5
Severine ARA VERMEIRE
ulcerative colitis inflammatory bowel disease mucosal healing
#6
Schreiber Schreiber
ulcerative colitis inflammatory bowel disease certolizumab pegol

Vandana Midha:Expert Impact

Concepts for whichVandana Midhahas direct influence:Ulcerative colitis,  Celiac disease,  North india,  Chronic hepatitis,  North indians,  Clinical remission,  Inflammatory bowel disease,  Pegylated interferon.

Vandana Midha:KOL impact

Concepts related to the work of other authors for whichfor which Vandana Midha has influence:Inflammatory bowel disease,  Ulcerative colitis,  Gut microbiota,  Liver failure,  Patients ibd,  Chronic hepatitis,  Complex traits.


 

Tools

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


Department of Gastroenterology, DMC, Ludhiana, India | Department of Internal Medicine, Dayanand Medical College, 141 001, Ludhiana, India | Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India | Dayanand Medical Col

download
FREE Custom List